Suppr超能文献

马萨诸塞州老年女性与年轻女性的宫颈癌发病率比较。

Cervical Cancer Incidence Among Elderly Women in Massachusetts Compared With Younger Women.

机构信息

Division Gynecologic Oncology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.

Department of Public Health, Harvard School of Public Health, Massachusetts Cancer Registry, Boston, MA.

出版信息

J Low Genit Tract Dis. 2018 Oct;22(4):314-317. doi: 10.1097/LGT.0000000000000435.

Abstract

IMPORTANCE

Current cancer screening guidelines recommend cessation of cervical cancer screening at the age of 65 years for most women. To examine residual risk among elderly women, we compared cervical cancer incidence rates (IRs) in Massachusetts from 2004 to 2015 among women younger than 65 years versus 65 years and older.

MATERIALS AND METHODS

The Massachusetts Cancer Registry was used to identify all women diagnosed with cervical cancer between January 01, 2004, to December 31, 2015. Cancer incidence was calculated based on age of diagnosis (<65 years vs ≥65 years).

RESULTS

In Massachusetts, 2,418 incident cases of cervical cancer were diagnosed from 2004 to 2014, of which 571 (23.6%) were diagnosed among women 65 years and older. When compared with women diagnosed younger than 65 years, women diagnosed at the age of 65 years and older were more likely to be diagnosed with stage II or higher (71.8% vs 43.8%, p < .001). Cervical cancer IRs decreased annually for women younger than 65 years from 2004 to 2015. Among women 65 years and older, cancer IRs decreased by 3.9% annually from 2004 to 2013 (p = .0009), but 2013 to 2015 showed an increasing trend (annual percent change + 14.1%, p = .12).

CONCLUSIONS AND RELEVANCE

Women 65 years and older account for one quarter of cervical cancer diagnoses in Massachusetts and present with higher-stage disease than younger women. Upcoming planned revisions in screening and prevention guidelines should address the continued risk of cervical cancer for older women.

摘要

重要性

目前的癌症筛查指南建议大多数女性在 65 岁时停止宫颈癌筛查。为了研究老年女性的剩余风险,我们比较了 2004 年至 2015 年马萨诸塞州 65 岁以下和 65 岁以上女性的宫颈癌发病率(IR)。

材料和方法

使用马萨诸塞州癌症登记处确定了 2004 年 1 月 1 日至 2015 年 12 月 31 日期间所有被诊断患有宫颈癌的女性。根据诊断年龄(<65 岁与≥65 岁)计算癌症发病率。

结果

在马萨诸塞州,2004 年至 2014 年诊断出 2418 例宫颈癌病例,其中 571 例(23.6%)诊断为 65 岁及以上的女性。与诊断年龄小于 65 岁的女性相比,诊断年龄为 65 岁及以上的女性更有可能被诊断为 II 期或更高期(71.8% vs 43.8%,p<0.001)。2004 年至 2015 年,65 岁以下女性的宫颈癌发病率每年下降。在 65 岁及以上的女性中,2004 年至 2013 年,癌症发病率每年下降 3.9%(p=0.0009),但 2013 年至 2015 年呈上升趋势(年变化百分比+14.1%,p=0.12)。

结论和相关性

65 岁及以上的女性占马萨诸塞州宫颈癌诊断的四分之一,与年轻女性相比,疾病处于更高阶段。即将进行的筛查和预防指南修订应解决老年女性持续存在的宫颈癌风险。

相似文献

1
Cervical Cancer Incidence Among Elderly Women in Massachusetts Compared With Younger Women.
J Low Genit Tract Dis. 2018 Oct;22(4):314-317. doi: 10.1097/LGT.0000000000000435.
2
Screening History Among Women with Invasive Cervical Cancer in an Academic Medical Center: Will We Miss Cancers Following Updated Guidelines?
J Womens Health (Larchmt). 2016 Aug;25(8):826-31. doi: 10.1089/jwh.2015.5394. Epub 2016 Feb 9.
3
Heavy cervical cancer burden in elderly women: how can we improve the situation?
Acta Cytol. 2012;56(4):388-93. doi: 10.1159/000338555. Epub 2012 Jul 25.
5
A Population-based Study of Invasive Cervical Cancer Patients in Beijing: 1993-2008.
Chin Med J (Engl). 2015 Dec 20;128(24):3298-304. doi: 10.4103/0366-6999.171420.
6
Effectiveness of cervical screening after age 60 years according to screening history: Nationwide cohort study in Sweden.
PLoS Med. 2017 Oct 24;14(10):e1002414. doi: 10.1371/journal.pmed.1002414. eCollection 2017 Oct.
7
The impact of health insurance status on the stage of cervical cancer diagnosis at a tertiary care center in Massachusetts.
Gynecol Oncol. 2018 Jul;150(1):67-72. doi: 10.1016/j.ygyno.2018.05.002. Epub 2018 May 9.
9
Aggressive characteristics of cervical cancer in young women in Taiwan.
Int J Gynaecol Obstet. 2009 Dec;107(3):220-3. doi: 10.1016/j.ijgo.2009.07.029. Epub 2009 Aug 27.
10
Does lowering the screening age for cervical cancer in The Netherlands make sense?
Int J Cancer. 2008 Sep 15;123(6):1403-6. doi: 10.1002/ijc.23652.

引用本文的文献

1
Trends in HPV-positive cervical cancer prevalence: a retrospective study from 2013 to 2020.
Virol J. 2025 Jun 18;22(1):199. doi: 10.1186/s12985-025-02830-7.
5
Prognostic nomogram for early-stage cervical cancer in the elderly: A SEER database analysis.
Prev Med Rep. 2024 Mar 26;41:102700. doi: 10.1016/j.pmedr.2024.102700. eCollection 2024 May.
6
Nomogram for prognosis of elderly patients with cervical cancer who receive combined radiotherapy.
Sci Rep. 2023 Aug 16;13(1):13299. doi: 10.1038/s41598-023-39764-5.
7
Insurance status and access to cervical cancer treatment in a specialized cancer center in Mexico.
Medicine (Baltimore). 2023 Apr 25;102(17):e33655. doi: 10.1097/MD.0000000000033655.
9
Cervical Cancer Stage at Diagnosis and Survival among Women ≥65 Years in California.
Cancer Epidemiol Biomarkers Prev. 2023 Jan 9;32(1):91-97. doi: 10.1158/1055-9965.EPI-22-0793.
10
Factors associated with timely colposcopy following an abnormal cervical cancer test result.
Prev Med. 2022 Nov;164:107307. doi: 10.1016/j.ypmed.2022.107307. Epub 2022 Oct 18.

本文引用的文献

1
How confident can we be in the current guidelines for exiting cervical screening?
Prev Med. 2018 Sep;114:188-192. doi: 10.1016/j.ypmed.2018.07.005. Epub 2018 Jul 5.
2
Assessment of treatment factors and clinical outcomes in cervical cancer in older women compared to women under 65 years old.
J Geriatr Oncol. 2018 Sep;9(5):516-519. doi: 10.1016/j.jgo.2018.02.004. Epub 2018 Mar 2.
3
Cervical Cancer Screening and Incidence by Age: Unmet Needs Near and After the Stopping Age for Screening.
Am J Prev Med. 2017 Sep;53(3):392-395. doi: 10.1016/j.amepre.2017.02.024. Epub 2017 May 1.
4
Recent trends in racial and regional disparities in cervical cancer incidence and mortality in United States.
PLoS One. 2017 Feb 24;12(2):e0172548. doi: 10.1371/journal.pone.0172548. eCollection 2017.
5
Hysterectomy-corrected cervical cancer mortality rates reveal a larger racial disparity in the United States.
Cancer. 2017 May 15;123(6):1044-1050. doi: 10.1002/cncr.30507. Epub 2017 Jan 23.
6
Differences in cervical cancer screening knowledge, practices, and beliefs: An examination of survey responses.
Prev Med Rep. 2016 Dec 21;5:169-174. doi: 10.1016/j.pmedr.2016.12.013. eCollection 2017 Mar.
7
Case-control study of cervical cancer and gynecologic screening: A SEER-Medicare analysis.
Gynecol Oncol. 2016 Sep;142(3):395-400. doi: 10.1016/j.ygyno.2016.06.016. Epub 2016 Jul 4.
8
Practice Bulletin No. 157: Cervical Cancer Screening and Prevention.
Obstet Gynecol. 2016 Jan;127(1):e1-e20. doi: 10.1097/AOG.0000000000001263.
9
Women's understanding of the term 'Pap smear'.
Matern Child Health J. 2015 Jul;19(7):1455-63. doi: 10.1007/s10995-015-1679-0.
10
Methods for evaluating changes in health care policy: the difference-in-differences approach.
JAMA. 2014 Dec 10;312(22):2401-2. doi: 10.1001/jama.2014.16153.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验